Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.55%EBITDA Margin
VS
Market
Sector
Industry
History
$ 3.16Close
$ 1.37 - $ 4.01 52-Week Range
Ticker Information
Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAKEBIA THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AKBA - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 15.38M | 7.55% | $ 203.73M |
| 3/31/2025 | $ 10.87M | 5.88% | $ 184.91M |
| 12/31/2024 | $ -9.52M | -5.95% | $ 160.18M |
| 9/30/2024 | $ 12.85M | 7.57% | $ 169.88M |
| 6/30/2024 | $ 11.86M | 6.8% | $ 174.5M |
| 3/31/2024 | $ 7.34M | 3.92% | $ 187.22M |
| 12/31/2023 | $ -4.05M | -2.08% | $ 194.62M |
| 9/30/2023 | $ -19.02M | -9.83% | $ 193.61M |
| 6/30/2023 | $ -54.19M | -27.03% | $ 200.53M |
| 3/31/2023 | $ -8.93M | -3.3% | $ 271.03M |
Key Performance Insights, Last 5 Years
- AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -114.49%.
- Over the past 5 years, AKEBIA THERAPEUTICS INC's average EBITDA % has been -45.13%.
- The median EBITDA % for AKEBIA THERAPEUTICS INC during this period was -20.62%
- AKEBIA THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 7.57%.
- The lowest EBITDA % recorded by AKEBIA THERAPEUTICS INC in the same timeframe -134.67%
AKEBIA THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for AKEBIA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -352.8M ] / Revenues [ $ 308.16M ]
(=) EBITDA % [ -114.49% ] AKBA - EBITDA Margin, Last 5 years
-134.67%
Minimum
Mar 31, 2021
7.57%
Maximum
Sep 30, 2024
-45.13%
Average
-20.62%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |